Azra Ghani
Visiting Professor at Lee Kong Chian School of Medicine/Professor in Infectious Disease Epidemiology at Imperial College London
Schools
- Imperial College London
Links
Biography
Imperial College London
Professor Azra Ghani is an infectious disease epidemiologist in the MRC Centre for Global Infectious Disease Analysis at Imperial College London. She has worked on a wide range of infectious diseases, including BSE and variant CJD, sexually transmitted infections including HIV, SARS, influenza and malaria. Since early 2020 she has been actively involved in supporting the public health response to the COVID-19 pandemic, advising the UK government and numerous international agencies on the scale of outbreaks and impact of interventions.
She is currently a member of the WHO Malaria Policy Advisory Committee and a policy advisor and trustee for the international charity Malaria No More UK. She was elected a Fellow of the Academy of Medical Sciences in 2017, awarded the Chalmers Medal by the Royal Society of Tropical Medicine and Hygiene in 2017, the Unilver Colworth Prize by the Microbiology Society in 2021 and appointed a Member of the British Order (MBE) in the 2021 Birthday Honours.
Selected Publications
Journal Articles
- Griffi JT, Bhatt S, Sinka ME, et al., 2016, Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study, Lancet Infectious Diseases, Vol:16, ISSN:1473-3099, Pages:465-472
- Slater HC, Ross A, Ouedraogo AL, et al., 2015, Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies, Nature, Vol:528, ISSN:0028-0836, Pages:S94-S101
- Ghani AC, Burgess DH, Reynolds A, et al., 2015, Expanding the role of diagnostic and prognostic tools for infectious diseases in resource-poor settings, Nature, Vol:528, ISSN:0028-0836, Pages:S50-S52
- White MT, Verity R, Griffin JT, et al., 2015, Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial, Lancet Infectious Diseases, Vol:15, ISSN:1473-3099, Pages:1450-1458
- Walker PGT, White MT, Griffin JT, et al., 2015, Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis, Lancet Infectious Diseases, Vol:15, ISSN:1473-3099, Pages:825-832
- White MT, Griffin JT, Riley EM, et al., 2011, Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines, Proceedings of the Royal Society B: Biological Sciences, Vol:278, ISSN:0962-8452, Pages:1298-1305
- Griffin JT, Hollingsworth TD, Okell LC, et al., 2010, Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies., Plos Med, Vol:7, ISSN:1549-1676, Pages:1-27
Videos
Ep 24 Science in Context - COVID-19 with Prof Azra Ghani (10-12-2021)
Protecting against COVID-19 – Vaccination approaches (Part 2/2) - Professor Azra Ghani
Ep 55 Science in Context - Malaria update with Prof Azra Ghani (16-12-2022)
Pr. Azra Ghani (Imperial College London) Modelling diagnostics for global health
Read about executive education
Other experts
Popular Courses
Leading People and Teams
ESMT
Berlin, Germany
May 28
The Manchester Leadership Development Programme
Alliance Manchester Business School
Manchester, United Kingdom
Jul 1
Leading Strategic Growth and Change
Columbia Business School
New York, New York, United States
Jun 10
Leading Digital Transformation
ESMT
Berlin, Germany
May 28
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Sep 8
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Jun 23
Looking for an expert?
Contact us and we'll find the best option for you.